News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Carmine Valenza: The Role of Germline BRCA Mutation in PARP Inhibitors-Related Hematologic Adverse Events
Carmine Valenza/X
Dec 5, 2024, 07:25

Carmine Valenza: The Role of Germline BRCA Mutation in PARP Inhibitors-Related Hematologic Adverse Events

Carmine Valenza, Medical Oncology Resident at the European Institute of Oncology, shared a post on X:

“Happy to share our last paper on the role of germline BRCA mutation in PARP inhibitors-related hematologic adverse events.

 No differences between carriers vs. non-carriers.

Thanks to all the coauthors, Eleonora Nicolò, Dario Trapani, Luca Boscolo Bielo, Lorenzo Guidi, G Curigliano.”

Title: Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study 

Authors: Carmine Valenza, Eleonora Nicolò, Marta Mongillo, Dario Trapani, Jalissa Katrini, Laura Boldrini, Luca Boscolo Bielo, Grazia Castellano, Lorenzo Guidi, Gloria Pellizzari, Jacopo Villa, Silvia Derio, Mariateresa Lapresa, Federica Gigli, Gabriella Parma, Emanuela Omodeo Salè, Enrico Derenzini, Giuseppe Curigliano and Nicoletta Colombo

Carmine Valenza

More posts featuring Carmine Valenza.

BRCA mutation cancer Carmine Valenza Dario Trapani Eleonora Nicolò Emanuela Omodeo Salè Enrico Derenzini germline Giuseppe Curigliano Gloria Pellizzari Grazia Castellano hematologic adverse events IEO Jacopo Villa Jalissa Katrini Laura Boldrini Lorenzo Guidi Luca Boscolo Bielo Mariateresa Lapresa Marta Mongillo Nicoletta Colombo OncoDaily Oncology PARP inhibitors Silvia Derio
Special Coverage
Insight
Dec 5, 2024, 07:25
Carmine Valenza: The Role of Germline BRCA Mutation in PARP Inhibitors-Related Hematologic Adverse Events
Insight
Dec 5, 2024, 00:57
Karen Knudsen: Vaccination against HPV is Cancer Prevention
Blog
Dec 5, 2024, 00:45
Richard Scolyer shared his Cancer Journey at Parliament House in Canberra
Insight
Dec 5, 2024, 00:41
Extreme wrinkling of the nuclear lamina is a morphological marker of cancer
Blog
Dec 5, 2024, 00:30
Akhil Kapoor: Every step forward is a step toward Hope
Blog
Dec 5, 2024, 00:24
Call for Applications for the 2025 SIOP Scientific Programme Advisory Working Group
Insight
Dec 5, 2024, 00:13
Alan Bryce: The manuscript from the 2024 United States Prostate Cancer Consensus Conference
Blog
Dec 5, 2024, 00:09
Manchester Cancer Research Centre’s Director’s Update – November 2024
Insight
Dec 4, 2024, 23:53
Miguel Bronchud: Interesting single-arm, open-label, phase 1 study on CRISPR Therapeutics by Swaminathan Iyer et al.
Blog
Dec 4, 2024, 23:50
Shirin Heidari discusses how the SAGER guidelines can help bridge the gender data gap in research - Gendro.org
Blog
Dec 4, 2024, 23:47
Narjust Florez: Oncologist’s perspective during the holidays "We pray for good scans for our patients"
Blog
Dec 4, 2024, 23:10
Nikolaos Zamboglou honored for innovation in healthcare - German Oncology Center